 <h1>Zemuron Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>rocuronium</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about rocuronium. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Zemuron.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to rocuronium: intravenous solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, rocuronium (the active ingredient contained in Zemuron) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking rocuronium:</p><p>
<i>Rare</i>
</p><ul>
<li>Cough</li>
<li>difficulty with breathing</li>
<li>dizziness</li>
<li>fainting</li>
<li>fast, slow, or irregular heartbeat</li>
<li>noisy breathing</li>
<li>swelling at the injection site</li>
<li>tightness in the chest</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Difficulty with swallowing</li>
<li>hives, itching, or skin rash</li>
<li>muscular pain, tenderness, wasting, or weakness</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<!-- end intravenous solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to rocuronium: intravenous solution</i></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Arrhythmia, abnormal electrocardiogram, tachycardia</p>
<p><b>Rare</b> (0.01% to 0.1%): Hypotension, hypertension </p>
<p><b>Very rare</b> (less than 0.01%): Circulatory collapse and shock, flushing<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Rare</b> (0.01% to 0.1%): Injection site edema, pruritus</p>
<p><b>Very rare</b> (less than 0.01%): Angioneurotic edema, urticaria, rash, erythematous rash<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Uncommon</b> (0.1% to 1%): Nausea, vomiting<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Very rare</b> (less than 0.01%): Hypersensitivity, anaphylactic reaction, anaphylactoid reaction, anaphylactic shock, anaphylactoid shock<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Asthma (bronchospasm, wheezing, or rhonchi), hiccup</p>
<p><b>Very rare</b> (less than 0.01%): Bronchospasm</p>
<p><b>Postmarketing reports</b>: Increased pulmonary vascular resistance<sup>[Ref]</sup></p><h3>Local</h3><p><b>Rare</b> (less than 0.1%): Injection site pain, injection site reaction<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Rare</b> (less than 0.1%): Prolonged neuromuscular block</p>
<p><b>Very rare</b> (less than 0.01%): Muscular weakness</p>
<p><b>Frequency not reported</b>: Residual paralysis, myopathy<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very rare</b> (less than 0.01%): Flaccid paralysis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Uncommon</b> (0.1% to 1%): Drug ineffective, drug effect/therapeutic response decreased, drug effect/therapeutic response increased</p>
<p><b>Frequency not reported</b>: Malignant hyperthermia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Rocuronium Bromide (rocuronium)." Hospira Inc, Lake Forest, IL. </p><p id="ref_3">3. "Product Information. Zemuron (rocuronium)." Organon, West Orange, NJ. </p><p id="ref_4">4. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Zemuron (rocuronium)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: neuromuscular blocking agents</li>
<li>FDA Alerts (2)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Zemuron &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Anesthesia</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to rocuronium: intravenous solution</i></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Arrhythmia, abnormal electrocardiogram, tachycardia</p><p><b>Rare</b> (0.01% to 0.1%): Hypotension, hypertension </p><p><b>Very rare</b> (less than 0.01%): Circulatory collapse and shock, flushing<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Rare</b> (0.01% to 0.1%): Injection site edema, pruritus</p><p><b>Very rare</b> (less than 0.01%): Angioneurotic edema, urticaria, rash, erythematous rash<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Uncommon</b> (0.1% to 1%): Nausea, vomiting<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Very rare</b> (less than 0.01%): Hypersensitivity, anaphylactic reaction, anaphylactoid reaction, anaphylactic shock, anaphylactoid shock<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Uncommon</b> (0.1% to 1%): Asthma (bronchospasm, wheezing, or rhonchi), hiccup</p><p><b>Very rare</b> (less than 0.01%): Bronchospasm</p><p><b>Postmarketing reports</b>: Increased pulmonary vascular resistance<sup>[Ref]</sup></p><h3>Local</h3><p><b>Rare</b> (less than 0.1%): Injection site pain, injection site reaction<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Rare</b> (less than 0.1%): Prolonged neuromuscular block</p><p><b>Very rare</b> (less than 0.01%): Muscular weakness</p><p><b>Frequency not reported</b>: Residual paralysis, myopathy<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very rare</b> (less than 0.01%): Flaccid paralysis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Uncommon</b> (0.1% to 1%): Drug ineffective, drug effect/therapeutic response decreased, drug effect/therapeutic response increased</p><p><b>Frequency not reported</b>: Malignant hyperthermia<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Rocuronium Bromide (rocuronium)." Hospira Inc, Lake Forest, IL. </p><p id="ref_3">3. "Product Information. Zemuron (rocuronium)." Organon, West Orange, NJ. </p><p id="ref_4">4. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p><h2>More about Zemuron (rocuronium)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: neuromuscular blocking agents</li>
<li>FDA Alerts (2)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Zemuron &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Anesthesia</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>